Drug Discovery Featured Articles & Applications

  1. $25 Million Awards Help Cancer Researchers Make Clinical Trial Inroads 5/9/2024

    Cancer Grand Challenges — a global research initiative cofounded by Cancer Research U.K. and the National Cancer Institute in the U.S. — supports cancer research that aims to answer some of the field’s most dire questions and pertinent needs.

  2. mRNA: The Fourth Pillar Of Pharmaceutical Innovation And Intervention 4/26/2024

    mRNA medicines represent the genesis of a fourth pillar of pharma innovation. While exciting, there are several critical challenges we must solve to strengthen this pillar, including stability and deliverability.

  3. Bucking Convention: How Analog Ibogaine Could Help Conquer CNS Disorders 4/22/2024

    EQUULUS Cofounder and CEO Robert Discordia discusses his company’s pursuit of an analog ibogaine as a potential therapy for CNS disorders.

  4. Innovating Bioequivalence: A Novel Approach To Developing Complex Generic Dosage Forms 4/16/2024

    Achieving bioequivalence for complex generics is an intricate task. This article describes an approach using in vitro–in vivo correlation, PBMK modeling, and more.

  5. Cell Counting Is Growing More Important Amid Advanced Therapy's Rise 4/12/2024

    You can't improve what you don't measure. This discussion explores advances in cell counting technology and the growing number of ways it aids the biotech industry and beyond.

  6. A Promising Approach To Develop An Inhalable, Temperature-Stable COVID-19 Vaccine 4/12/2024

    There are limitations to the currently available COVID-19 vaccines. An inhalable dry powder approach offers promising benefits, such as eliminating cold chain requirements, allowing for more widespread immunity.

  7. AI Is Unearthing New Drug Candidates, But It Still Needs Human Oversight 4/11/2024

    AI can accelerate timetables and minimize wasted resources by analyzing vast amounts of data, but human oversight is necessary to address the limitations and biases of AI systems.

  8. 2024 CIO Survey Reveals IT Budgets, AI Priorities For Life Sciences Companies 4/9/2024

    Clarkston Consulting conducted its third annual Chief Information Officer (CIO) Survey to understand IT budgets of life sciences companies, how AI priorities fit into those budgets, and more.

  9. AI And Pharmaceutical Development: WHO Calls For Ethical Framework, Good Governance 4/8/2024

    The World Health Organization (WHO) recently released a document titled Benefits and risks of using artificial intelligence for pharmaceutical development and delivery describing the ethical issues and governance considerations for using AI in drug discovery, preclinical development, and clinical trials.

  10. AI Technologies Drive Drug Development And Enhance Patient Experience In Neurology & Rare Diseases 3/21/2024

    Digital healthcare and AI technologies play a crucial role in exploring and treating a range of rare diseases as we welcome a new era of personalized care and potentially better patient outcomes.